Recent advances in technology have made it easier to treat cancerous cells located near vital areas of the body. One such device – the NanoKnife® System – uses electrical currents to surgically destroy tumors in soft tissue areas without damaging the surrounding veins, vessels and ducts.
Carol G. Simon Cancer Center at Morristown Medical Center is the first in New Jersey to provide patients with this type of surgical ablation – also known as irreversible electroporation (IRE). It allows surgeons to treat tumors in difficult locations that previously would have been inoperable. Additional benefits of NanoKnife include improved patient outcomes and reduced chances of disease reoccurrence.
Our medical professionals, who are trained by the pioneer of this technology, use NanoKnife to treat those with localized pancreatic and liver cancers, as well as other tumors that would be troublesome to remove with conventional techniques.